| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 139,807 | 148,837 | 163,495 | 168,364 | | Cost of Revenue | 18,409 | 22,277 | 28,037 | 35,049 | | | Gross Profit |
-
| 126,560 | 135,458 | 133,315 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 81,667 | 49,501 | 69,377 | 81,274 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 20,449 | 44,524 | 50,552 | 45,785 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 32,535 | 15,529 | 6,256 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 19,282 | 32,535 | 15,529 | 6,256 | | Interest Expense | 11,615 | 11,625 | 16,245 | 16,976 | | Income Before Tax | 7,667 | 20,910 | (716) | (10,720) | | Income Tax Expense | (2,805) | 8,826 | (685) | (5,175) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,472 | 12,084 | (31) | (5,545) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,472 | 12,084 | (31) | (5,545) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,472 | $12,084 | ($31) | ($5,545) |
|
0.11% Nasdaq 0.00%
Income Statement
